GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types

被引：18

作者：

Sievers, Philipp ^{[1
,2
]}

Stichel, Damian ^{[1
,2
]}

Sill, Martin ^{[3
,4
]}

Schrimpf, Daniel ^{[1
,2
]}

Sturm, Dominik ^{[3
,5
,25
]}

Selt, Florian ^{[3
,5
,6
]}

Ecker, Jonas ^{[3
,5
,6
]}

Kazdal, Daniel ^{[7
]}

Miele, Evelina ^{[8
]}

Kranendonk, Marieatte E. G. ^{[9
]}

Tops, Bastiaan B. J. ^{[9
]}

Kohlhof-Meinecke, Patricia ^{[10
]}

Beschorner, Rudi ^{[11
]}

Kramm, Christof M. ^{[12
]}

Hasselblatt, Martin ^{[13
]}

Reifenberger, Guido ^{[14
,15
]}

Capper, David ^{[16
,17
,18
,19
]}

Wesseling, Pieter ^{[9
,20
,21
]}

Stenzinger, Albrecht ^{[7
]}

Milde, Till ^{[3
,5
,6
]}

Korshunov, Andrey ^{[1
,2
,3
]}

Witt, Olaf ^{[3
,5
,6
]}

Pfister, Stefan M. ^{[3
,4
,5
]}

Wick, Wolfgang ^{[22
,23
,24
]}

von Deimling, Andreas ^{[1
,2
]}

Jones, David T. W. ^{[3
,25
]}

Sahm, Felix ^{[1
,2
,3
]}

机构：

[1] Univ Hosp Heidelberg, Inst Pathol, Dept Neuropathol, Heidelberg, Germany

[2] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neuropathol, Heidelberg, Germany

[3] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[4] German Canc Res Ctr, German Canc Consortium DKTK, Div Pediat Neurooncol, Heidelberg, Germany

[5] Univ Hosp Heidelberg, Dept Pediat Oncol Hematol Immunol & Pulmonol, Heidelberg, Germany

[6] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Pediat Oncol, Heidelberg, Germany

[7] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany

[8] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Oncohematol & Cell & Gene Therapy, Rome, Italy

[9] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands

[10] Klinikum Stuttgart, Dept Pathol, Stuttgart, Germany

[11] Univ Tubingen, Dept Neuropathol, Tubingen, Germany

[12] Univ Med Ctr Gottingen, Div Pediat Hematol & Oncol, Gottingen, Germany

[13] Univ Hosp Munster, Inst Neuropathol, Munster, Germany

[14] Heinrich Heine Univ, Inst Neuropathol, Dusseldorf, Germany

[15] German Canc Consortium DKTK, Partner Site Essen Dusseldorf, Dusseldorf, Germany

[16] Charite Univ Med Berlin, Berlin, Germany

[17] Free Univ Berlin, Berlin, Germany

[18] Humboldt Univ, Inst Neuropathol, Berlin, Germany

[19] German Canc Res Ctr, German Canc Consortium DKTK, Partner Site Berlin, Heidelberg, Germany

[20] Amsterdam Univ Med Ctr, Locat VUmc, Dept Pathol, Amsterdam, Netherlands

[21] Brain Tumor Ctr Amsterdam, Amsterdam, Netherlands

[22] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neurooncol, Heidelberg, Germany

[23] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Dept Neurol, Heidelberg, Germany

[24] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Neurooncol Program, Heidelberg, Germany

[25] German Canc Res Ctr, Pediat Glioma Res Grp, Heidelberg, Germany

来源：

ACTA NEUROPATHOLOGICA | 2021年 / 142卷 / 06期

关键词：

CRIZOTINIB;

D O I：

10.1007/s00401-021-02369-1

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

下载

页码：1065 / 1069

页数：5

共 50 条

[31] ROS1 Rearrangement in Thyroid Cancer
Ritterhouse, Lauren L.
Wirth, Lori J.
Randolph, Gregory W.
Sadow, Peter M.
Ross, Douglas S.
Liddy, Whitney
Lennerz, Jochen K.
THYROID, 2016, 26 (06) : 794 - 797
[32] Expanding the Roster of ROS1 Inhibitors
Dagogo-Jack, Ibiayi
Shaw, Alice T.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2595 - +
[33] Immunohistochemical Detection of ROS1 Fusion
Su, Yuhua
Goncalves, Theodore
Dias-Santagata, Dora
Hoang, Mai P.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 77 - 82
[34] ROS1 RNA In Situ Hybridization (RNA-ISH) for Detecting ROS1 Rearrangements in Lung Adenocarcinoma
Helland, Timothy
Neyaz, Azfar
Deshpande, Vikram
Hung, Yin
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1781 - 1781
[35] Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
Lin, Jessica J.
Langenbucher, Adam
Gupta, Pranav
Yoda, Satoshi
Fetter, Isobel J.
Rooney, Marguerite
Do, Andrew
Kem, Marina
Chang, Kylie Prutisto
Oh, Audris Y.
Chin, Emily
Juric, Dejan
Corcoran, Ryan B.
Dagogo-Jack, Ibiayi
Gainor, Justin F.
Stone, James R.
Lennerz, Jochen K.
Lawrence, Michael S.
Hata, Aaron N.
Mino-Kenudson, Mari
Shaw, Alice T.
NPJ PRECISION ONCOLOGY, 2020, 4 (01)
[36] ALK and ROS1 Overexpression is Very Rare in Colorectal Adenocarcinoma
Houang, Michelle
Toon, Christopher W.
Clarkson, Adele
Sioson, Loretta
de Silva, Keshani
Watson, Nicole
Singh, Nisha R.
Chou, Angela
Gill, Anthony J.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (02) : 134 - 138
[37] ROS1: Rearrangements und Analytik
Siebolts, Udo
Merkelbach-Bruse, Sabine
PATHOLOGIE, 2023, 44 (01): : 50 - 52
[38] Detection of ROS1 Rearrangement Using Immunohistochemistry: Correlation With ROS1 Fusion Analysis by Fluorescence In Situ Hybridization
Coffman, Brittany
Hettinga, Ana
Buehler, Karen
Vasef, Mohammad
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S26 - S27
[39] Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
Jessica J. Lin
Adam Langenbucher
Pranav Gupta
Satoshi Yoda
Isobel J. Fetter
Marguerite Rooney
Andrew Do
Marina Kem
Kylie Prutisto Chang
Audris Y. Oh
Emily Chin
Dejan Juric
Ryan B. Corcoran
Ibiayi Dagogo-Jack
Justin F. Gainor
James R. Stone
Jochen K. Lennerz
Michael S. Lawrence
Aaron N. Hata
Mari Mino-Kenudson
Alice T. Shaw
npj Precision Oncology, 4
[40] Correlation of ROS1 (SP384) Immunohistochemistry with ROS1 Rearrangement Determined by Fluorescence in Situ Hybridization
Huang, R.
Smith, D.
Richardson, B.
Le, C.
Liu, W.
Newell, A. Hanlon
Pate, G.
Menzl, I.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S766 - S766

← 1 2 3 4 5 →